SCHEMBL196737

SCHEMBL196737

Clc1cccc2nc[nH]c12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.56
AURKA O14965 1/20 0.43
DAPK3 O43293 1/20 0.43
JAK2 O60674 1/20 0.43
PRKD3 O94806 1/20 0.43
MAP4K4 O95819 1/20 0.43
PAK4 O96013 1/20 0.43
ABL1 P00519 1/20 0.43
CSF1R P07333 1/20 0.43
RET P07949 1/20 0.43
IGF1R P08069 1/20 0.43
MET P08581 1/20 0.43
PDGFRB P09619 1/20 0.43
PIM1 P11309 1/20 0.43
FGFR1 P11362 1/20 0.43
PDGFRA P16234 1/20 0.43
PRKACA P17612 1/20 0.43
FLT1 P17948 1/20 0.43
LTK P29376 1/20 0.43
GRK5 P34947 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL196912 0.77 PARP1 (0.42) PARP1ABL1ACVR1ALOX15PDPK1
SCHEMBL3232202 0.76 PARP1 (0.41) PARP1ABL1CLK2GSK3BDYRK1A
SCHEMBL30036694 0.74 PARP1 (0.43) PARP1LRRK2ALOX15PDPK1CA12
SCHEMBL4130388 0.74 PARP1 (0.56) PARP1CDK5ALOX15PDPK1CA12
SCHEMBL1445123 0.74 PDPK1 (0.41) PARP1PIM1GSK3BCDK9CDK5
SCHEMBL1019602 0.74 QPCT (0.42) PARP1FGFR1ALOX15PDPK1CA12
SCHEMBL29805281 0.74 CSNK2A1 (0.39) PARP1AURKADAPK3PRKD3MAP4K4
SCHEMBL4535251 0.74 CSNK2A1 (0.39) PARP1AURKADAPK3PRKD3MAP4K4
SCHEMBL312428 0.74 PARP1 (0.43) PARP1LRRK2ALOX15PDPK1CA12
SCHEMBL8668 0.74 PARP1 (0.56) PARP1AHRACP1ALOX15PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3720843-A1 MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE GlaxoSmithKline Intellectual Property Development Limited (GB) 2020-10-14 EP claimed
US-20200291008-A1 MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-09-17 US claimed
CN-111417626-A Modulators of indoleamine2,3-dioxygenase 葛兰素史克知识产权开发有限公司 2020-07-14 CN claimed
WO-2019111107-A1 MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-06-13 WO claimed
US-20100087478-A1 HIF-1 Inhibitors NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-04-08 US claimed
WO-2024163380-A1 SUBSTITUTED BENZIMIDAZOLE COMPOUNDS USEFUL AS INHIBITORS OF TLR9 BRISTOL-MYERS SQUIBB COMPANY (US) 2024-08-08 WO disclosed
US-20240025861-A1 METHODS OF COUPLING A CARBON CONTAINING MOIETY TO AN AMINE CONTAINING MOIETY PURDUE RESEARCH FOUNDATION 2024-01-25 US disclosed
US-11787770-B2 Methods of coupling a carbon containing moiety to an amine containing moiety PURDUE RESEARCH FOUNDATION (US) 2023-10-17 US disclosed
US-20210363111-A1 METHODS OF COUPLING A CARBON CONTAINING MOIETY TO AN AMINE CONTAINING MOIETY PURDUE RESEARCH FOUNDATION 2021-11-25 US disclosed
EP-3720843-A1 MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE GlaxoSmithKline Intellectual Property Development Limited (GB) 2020-10-14 EP disclosed
US-20200291008-A1 MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-09-17 US disclosed
CN-111417626-A Modulators of indoleamine2,3-dioxygenase 葛兰素史克知识产权开发有限公司 2020-07-14 CN disclosed
EP-0395069-A2 Silver halide photographic materials FUJI PHOTO FILM CO., LTD. (JP) 1990-10-31 EP disclosed
EP-0393720-A2 Silver halide photographic materials FUJI PHOTO FILM CO., LTD. (JP) 1990-10-24 EP disclosed
EP-0335319-A2 Silver halide photographic material FUJI PHOTO FILM CO., LTD. (JP) 1989-10-04 EP disclosed
US-4737442-A INCLUDING A SENSITIZER AND A BLOCKED DEVELOPMENT RESTRAINER; FREE OF BLACK SPOTS FUJI PHOTO FILM CO., LTD. (JP) 1988-04-12 US disclosed
US-4585472-A PRE- AND POSTEMERGENCE HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 1986-04-29 US disclosed
US-4030926-A Light-sensitive material containing a dye-forming combination of a heterocyclic compound and a cyclic dihalodicarbonyl compound in a polymeric binder AGFA-GEVAERT, A.G. (DT) 1977-06-21 US disclosed
US-3988155-A CYANINE SENSITIZING DYES FUJI PHOTO FILM CO., LTD. (JA) 1976-10-26 US disclosed
US-3985563-A Silver halide photographic emulsion FUJI PHOTO FILM CO., LTD. (JA) 1976-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210363111-A1 METHODS OF COUPLING A CARBON CONTAINING MOIETY TO AN AMINE CONTAINING MOIETY HCCS, PAICS, PNMT PARP1 528/4885AURKA 71/4885DAPK3 3251/4885
US-11787770-B2 Methods of coupling a carbon containing moiety to an amine containing moiety HCCS, PAICS, PNMT PARP1 528/4885AURKA 71/4885DAPK3 3251/4885
US-20240025861-A1 METHODS OF COUPLING A CARBON CONTAINING MOIETY TO AN AMINE CONTAINING MOIETY HCCS, PAICS, PNMT PARP1 528/4885AURKA 71/4885DAPK3 3251/4885
US-20100087478-A1 HIF-1 Inhibitors HIF1AN, HIF1A, EGLN2 PARP1 1198/4885AURKA 4372/4885DAPK3 1186/4885
US-20200291008-A1 MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE IDO1, IDO2, TPH1 PARP1 1977/4885AURKA 3368/4885DAPK3 1702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.